Aditxt

Aditxt Goodwill/Assets

The Goodwill to Total Assets Ratio of Aditxt (ADTX) as of Oct 18, 2026 is 18.99 %.

Goodwill/Assets

18.99 %

Last updated:

Goodwill to Total Assets Ratio of Aditxt is 2024 18.99 % . Goodwill to Total Assets Ratio of Aditxt was 2023 - . It decreases by % lower compared to the previous year.

The Aditxt Goodwill/Assets history

The Aditxt Goodwill/Assets history
YEARGoodwill/AssetsYoY
18.99 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aditxt Stock analysis

What does Aditxt do? Aditxt Inc, headquartered in Mountain View, California, is a preclinical-stage biotechnology company operating in the Health Care sector. The company develops nucleic acid-based technologies, including Apoptotic DNA Immunotherapy (ADi) and Aditxt Immune Monitor (AiM), aimed at minimizing organ transplant rejection and addressing autoimmune diseases through immune reprogramming and personalized immune monitoring. Listed on 19 June 2020, Aditxt focuses on advancing immune system health via innovative therapeutic approaches. Aditxt is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aditxt stock

Goodwill to Total Assets Ratio of Aditxt is 18.99 % in 2024.

On Eulerpool you can find the complete historical development of Goodwill to Total Assets Ratio Aditxt since 2006 – with annual values, charts, and detailed analysis.

The Goodwill/Assets ratio shows what percentage of total assets consists of acquisition goodwill. High ratios may indicate impairment risk.

Goodwill to Total Assets Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill to Total Assets Ratio's Aditxt historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Aditxt

All Key Metrics — Aditxt